Health Care & Life Sciences » Pharmaceuticals | Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
2.50
16.60
15.40
Gross Income
-
-
2.50
16.60
15.40
SG&A Expense
38.60
1,572.60
4,316.10
6,107.70
8,911.30
EBIT
38.60
1,572.60
4,318.60
6,124.40
8,926.60
Pretax Income
38.60
1,565.30
4,215.00
6,098.70
8,872.70
Income Tax
-
-
1,290.60
1,823.30
2,682.50
Consolidated Net Income
38.60
1,565.30
2,924.40
4,275.40
6,190.20
Net Income
38.60
1,565.30
2,924.40
4,275.40
6,190.20
Net Income After Extraordinaries
38.60
1,565.30
2,924.40
4,275.40
6,190.20
Net Income Available to Common
38.60
1,565.30
2,924.40
4,275.40
6,190.20
EPS (Basic)
248.86
0.05
0.04
0.04
0.05
Basic Shares Outstanding
87,580.20
87,580.20
81,234.00
95,579.00
113,453.50
EPS (Diluted)
0.00
0.02
0.04
0.04
0.05
Diluted Shares Outstanding
87,580.20
87,580.20
81,234.00
95,579.00
113,453.50
EBITDA
38.60
1,572.60
4,316.10
6,107.70
8,911.30
Non-Operating Interest Income
-
7.30
103.60
25.60
53.90

About Paradigm Biopharmaceuticals

View Profile
Address
517 Flinders Lane
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.paradigmbiopharma.com
Updated 07/08/2019
Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company, engages in researching and developing therapeutic products for human use. It is a drug repurposing company which seeks to find new uses for old drugs. Paradigm Biopharmaceuticals was founded on May 2, 2014 and is headquartered in Melbourne, Australia.